« Back
Home > Keratin 18 MAbs
M5 and M6 Cytokeratin 18 Monoclonal Antibodies (K18) Research Use Only Cat. No. #10600-10650
M5 and M6 Cytokeratin 18 Monoclonal Antibodies (K18) Research Use Only Cat. No. #10600-10650
M5 and M6 Cytokeratin 18 Monoclonal Antibodies (K18) Research Use Only Cat. No. #10600-10650
M5 and M6 Cytokeratin 18 Monoclonal Antibodies (K18) Research Use Only Cat. No. #10600-10650

M5 and M6 Cytokeratin 18 Monoclonal Antibodies (K18) Research Use Only Cat. No. #10600-10650

The keratins are conserved phylogenetically and are closely related. Keratins 1-8 constitute the type II group, while keratins 9-20 constitute the type I group. Keratins provide useful markers for epithelial malignancies, distinctly reflecting ongoing cellular turnover. Certain keratins are substrates for lethal caspase activation and therefore define protein fragments during cell death.
Price on enquiry
Please apply for an account >

Choose your options

M5 / M6 Keratin 18 (Cytokeratin 18) monoclonal antibodies (FFPE-grade) (Prod. No. 10600-10650)

In eukaryotic cells, the cytoskeleton is composed of three different types of morphologically distinct filamentous structures:

  • microfilaments,
  • intermediate filaments (IF)
  • microtubules.

The epithelial keratins (IF types I and II, also called cytokeratins) are conserved phylogenetically and are closely related, biochemically and immunologically. Keratins 1-8 constitute the type II group (53-68 kDa, neutral to basic protein components), while keratins 9-20 constitute the type I group (40-56 kDa, acidic proteins).

Upon release from dying cells, keratins provide useful markers for epithelial malignancies, distinctly reflecting ongoing cellular turnover. Certain keratins, the most prominent example being keratin 18, are substrates for lethal caspase activation and the subsequent release of defined protein fragments occurs during apoptotic cell death.

The clinical value of determining different soluble keratin protein fragments in blood samples (i.e. using the M30 Apoptosense® ELISA or M65® ELISA) lies in the rapid and non-invasive assessment of drug efficacy or response to therapy in epithelial cell carcinomas.
 

Download Product Resources
Instructions of Use (CE-IVD)
Manuals (RUO)
Material Safety Data Sheets
Brand PEVIVA
Code 10600

Instructions of Use (CE-IVD)

 COVID-19 Antigen Rapid Test
 M30 Apoptosense® ELISA
 M65® ELISA
 M65 EpiDeath® ELISA
 M65 EpiRatTM ELISA

Manuals (RUO)

 M30 CytoDeath™ ELISA
 M30 CytoDEATH™ MAb
 M30 CytoDEATH™ FITC MAb
 M30 CytoDEATH™ BIOTIN MAb
 M30 CytoDEATH™ Orange MAb
 M6 Keratin 18 MAb
 M5 Keratin 18 MAb

Material Safety Data Sheets

 M30 Apoptosense ELISA MSDS
 M65® ELISA MSDS
 M65 EpiDeath® ELISA MSDS
 M30 CytoDeath™ ELISA MSDS
 M30 CytoDEATH™ MAb MSDS
 M30 CytoDEATH™ FITC MAb MSDS
 M30 CytoDEATH™ BIOTIN MAb MSDS
 M30 CytoDEATH™ Orange MAb MSDS
 M6 Keratin 18 MAb MSDS
M5 Keratin 18 MAb MSDS

Other Documents

 COVID-19 Antigen Rapid Test Declaration of Conformity
 COVID-19 Antigen Rapid Test Clinical Study Protocol

Related Products

  • M65® ELISA (classic) Cat. No. #10020

    M65® ELISA (classic) Cat. No. #10020

    The M65® ELISA is capable of measuring the amount of Keratin 18 that is released from the dying cells of many cell cultures that are from the extracellular compartment. The M65® ELISA offers the opportunity to quantify total cell death of K18 positive cells.
  • M30 CytoDeath™ ELISA RUO Cat. No. #10900

    M30 CytoDeath™ ELISA RUO Cat. No. #10900

    The M30 CytoDeath™ ELISA is a unique product specifically for cell culture applications. This is a powerful drug screening tool and is useful for in vitro characterisation of apoptosis-inducing drugs. It also offer the ability to quantify apoptosis in multicellular spheroids and organ culture systems.